Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Clarithromycin impurity 4, also known as N-Desmethyl Clarithromycin, functions as a drug impurity of Clarithromycin. This compound is utilized primarily for method development and validation in the analysis of Clarithromycin and its related substances. It aids in assessing the purity and quality of pharmaceutical formulations. -
Drug Impurity
Tipiracil Impurity 1 is a known impurity of the chemotherapeutic agent Tipiracil, which acts as a thymidine phosphorylase inhibitor. This impurity is significant in drug development and quality control processes, helping to ensure the purity and safety of pharmaceutical formulations containing Tipiracil. Its characterization is crucial for understanding the drug's profile and potential impacts in therapeutic applications. -
Drug Impurity
Azithromycin impurity 3, also known as 2-Desethyl-2-propylazithromycin, is a drug impurity associated with Azithromycin. This compound serves as a reference standard for analytical studies and is essential for the quality control of Azithromycin formulations. It is commonly utilized in research applications focused on the identification and quantification of impurities in pharmaceutical products. -
Drug Impurity
Domperidone impurity 1 is a significant impurity of the antiemetic medication Domperidone. As a byproduct of the drug's synthesis, it serves as an important reference for quality control and method development in pharmaceutical research. This reagent is essential for analytical studies to ensure the purity and compliance of Domperidone formulations in pharmaceutical applications. -
Drug Impurity
Haloperidol impurity 2 is a chemical impurity associated with the antipsychotic agent Haloperidol. This compound is primarily used for research applications to assess the purity and stability of Haloperidol formulations. Its presence in pharmaceutical development is critical for quality control and ensuring compliance with regulatory requirements. -
Drug Impurity
Alfuzosin EP impurity 2, also known as N2-Methyl alfuzosin, is a recognized impurity associated with the pharmaceutical compound Alfuzosin. This chemical structure serves as a valuable reference in the evaluation of drug purity and quality control in pharmaceutical research. It is useful for studies related to the pharmacokinetics and safety assessment of alfuzosin-based formulations. -
Drug Impurity
Mirabegron impurity 6 is a recognized impurity of the pharmaceutical compound Mirabegron, which primarily acts as a β3-adrenergic receptor agonist. It serves as an important reference standard for quality control in the synthesis and analysis of Mirabegron and is crucial in ensuring the purity and efficacy of the drug. This impurity can assist in research applications involving pharmacokinetics, safety assessments, and metabolic studies of β3-adrenergic modulators. -
Drug Impurity
Albendazole impurity 4 is a chemical impurity associated with the antifungal agent Albendazole, which primarily targets helminthic diseases. This impurity can be utilized in pharmacological research to assess the purity of Albendazole formulations and to study its degradation products. It plays an important role in quality control and regulatory compliance during drug development. -
Drug Impurity
Azithromycin impurity 5, also known as Azithromycin B, is a degradation product of Azithromycin. This impurity is relevant for quality control and analytical studies in pharmaceutical research. It can provide insights into the stability and integrity of Azithromycin formulations, aiding in the evaluation of drug purity and efficacy. -
Drug Impurity
Febuxostat impurity 12 is a chemical impurity associated with Febuxostat, a selective inhibitor of xanthine oxidase. This compound is important for analytical and quality control purposes in pharmaceutical research, particularly in the assessment of the purity of Febuxostat formulations. It serves as a reference standard for the identification and quantification of impurities during drug development and testing stages. -
Drug Impurity
Roxithromycin impurity 6 is a synthetic impurity associated with Roxithromycin, a macrolide antibiotic. This compound is vital for quality control and analytical research in pharmaceutical development, aiding in the characterization and assessment of Roxithromycin formulations. Understanding such impurities is crucial for ensuring drug safety and efficacy in clinical applications. -
Drug Impurity
Ethinylestradiol impurity 1, also known as 9,11-Dehydro ethynyl estradiol, is a derivative and impurity of the synthetic estrogen Ethinylestradiol. This compound is used primarily as a reference standard in the quality control of pharmaceutical formulations containing Ethinylestradiol. Its presence can affect the overall efficacy and safety profiles of estrogen-based therapies, making it critical for analytical testing in drug development and regulatory compliance. -
Drug Impurity
Levothyroxine impurity 13 is a drug impurity associated with Levothyroxine. This compound is primarily used for analytical purposes in pharmaceutical research to ensure the purity and quality of Levothyroxine formulations. Its presence and characterization are crucial for regulatory compliance and the development of safer therapeutic agents. -
Drug Impurity
Rifampicin Impurity 1 is a known impurity associated with Rifampicin, a potent antibiotic targeting bacterial RNA polymerase. This compound is primarily utilized in pharmaceutical research to assess the purity of Rifampicin formulations and ensure compliance with quality standards. Its presence may influence the efficacy and safety profile of Rifampicin, making it a valuable reagent for analytical chemistry and regulatory studies in drug development. -
Drug Impurity
Citalopram impurity 7 is a known impurity associated with Citalopram, a selective serotonin reuptake inhibitor (SSRI). This compound is useful for analytical purposes in the development and quality control of pharmaceutical formulations containing Citalopram. It aids in understanding the stability, degradation pathways, and overall purity of the drug within research applications. -
Drug Impurity
Fenirofibrate impurity 7 is a chemical impurity associated with Fenirofibrate. This compound can be used for analytical purposes in pharmacological research and quality control of pharmaceutical formulations. It is essential for understanding the pharmacokinetics and safety profile of Fenirofibrate, aiding in the assessment of drug purity and stability. -
Drug Impurity
Levetiracetam impurity 2, also known as Levetiracetam dehydro acid, is a chemical impurity associated with the anticonvulsant drug Levetiracetam. It plays a role in the assessment of drug quality and stability during pharmaceutical analysis. This compound is essential for researchers investigating the pharmacological properties and potential effects of impurities in drug formulations. -
Drug Impurity
Edoxaban impurity 18 is a chemical impurity associated with Edoxaban, an oral anticoagulant that targets factor Xa in the coagulation cascade. This impurity is critical for the assessment of drug purity and stability in pharmaceutical research and development. It serves as a valuable reference standard for the analysis and quality control of Edoxaban formulations. -
Drug Impurity
Rivaroxaban impurity 31 is a known impurity associated with the anticoagulant agent Rivaroxaban, functioning primarily as a drug impurity. This compound is utilized for analytical purposes in pharmaceutical research, particularly in the assessment of drug purity and the development of quality control methods. It may play a crucial role in stability studies and impurity profiling in pharmacological formulations. -
Drug Impurity
Rivaroxaban impurity 7 is a known impurity associated with Rivaroxaban, a selective factor Xa inhibitor. This compound is utilized primarily in the quality control and analytical characterization of Rivaroxaban formulations. Its presence and quantification are crucial for ensuring the purity and safety of pharmaceutical products containing Rivaroxaban. -
Drug Impurity
Cetirizine Impurity 12 is a chemical impurity associated with Cetirizine, an antihistamine commonly used for allergy relief. This compound serves as a reference standard for analytical studies, including stability testing and quality control in pharmaceutical formulations. Its evaluation is crucial for ensuring the purity and safety of Cetirizine in drug development and manufacturing processes. -
Drug Impurity
(R)-Citalopram is a stereoisomer of the selective serotonin reuptake inhibitor (SSRI) citalopram, typically investigated as a drug impurity. It may exhibit biological activity associated with serotonergic pathways, providing insights into pharmacological effects and safety profiles of citalopram formulations. This compound can serve as a valuable reference standard in quality control and pharmacokinetic studies. -
Drug Impurity
Tamsulosin impurity 15 is a chemical impurity associated with the pharmaceutical compound Tamsulosin, which primarily targets alpha-1 adrenergic receptors. This impurity is relevant for quality control and characterization in the development and analysis of Tamsulosin formulations. Research applications include assessing the purity and safety profiles of Tamsulosin in pharmaceutical formulations. -
Drug Impurity
Apixaban 4,5-dehydro carboxylic acid ethyl ester is a known drug impurity associated with the anticoagulant Apixaban. This impurity may influence the pharmacokinetic and pharmacodynamic profiles of the parent compound, making it relevant for bioanalytical studies and quality control during drug development. Researchers can utilize this compound to investigate the stability and degradation pathways of Apixaban, as well as to assess the potential impacts of impurities on therapeutic efficacy. -
Drug Impurity
Atorvastatin impurity 6 sodium, also known as Atorvastatin lactam impurity sodium, is a pharmaceutical impurity related to Atorvastatin sodium. This compound serves as a critical reference standard in the analysis of drug substances and quality control processes. Its characterization is essential for ensuring compliance with regulatory standards and for studying the stability and safety profiles of atorvastatin-related pharmaceuticals. -
Drug Impurity
Hydrocortisone impurity 6, also known as 21-Dehydrocortisol, is a recognized impurity of hydrocortisone. This compound is significant in the study of drug purity and stability, serving as a reference standard for analytical methods in pharmaceutical research. Its evaluation helps in understanding the degradation pathways of hydrocortisone and assessing the quality of pharmaceutical formulations. -
Drug Impurity
Sertraline impurity 11 is a known impurity associated with the selective serotonin reuptake inhibitor (SSRI) sertraline. This compound is critical for analytical and quality control processes in pharmaceutical research, enabling accurate assessment of sertraline's purity and formulation stability. Its characterization is essential for regulatory compliance and the development of robust analytical methods in drug formulation studies. -
Drug Impurity
Carvedilol impurity 5 is a known impurity of the β-blocker carvedilol. This compound is significant for researchers assessing the purity of carvedilol formulations and studying its pharmacokinetics. Understanding this impurity can aid in the development of more effective and safer cardiovascular therapies. It serves primarily in quality control processes and analytical method development within pharmaceutical research. -
Drug Impurity
Duloxetine impurity 8 hydrochloride is a characterized impurity of Duloxetine hydrochloride, primarily serving as a reference standard in analytical and quality control applications. This compound is critical for evaluating the purity of Duloxetine formulations and ensuring compliance with regulatory standards. It aids in the development and stability testing of pharmaceutical products containing Duloxetine. -
Drug Impurity
N-(2,6-dimethylphenyl)-2-(ethyl(methyl)amino)acetamide hydrochloride is a recognized impurity associated with the sodium channel inhibitor Lidocaine. This compound may serve as a reference standard for quality control and analytical studies within pharmacological research. It can aid in the assessment of drug purity and the validation of analytical methods used in drug development and manufacturing processes. -
Drug Impurity
Tamsulosin impurity 1 is a chemical impurity associated with the pharmaceutical agent Tamsulosin. It is primarily used in the analysis of drug purity and quality control in pharmaceutical research and development. Its presence can be critical in understanding the pharmacological properties and safety profile of Tamsulosin, facilitating regulatory compliance and ensuring therapeutic efficacy. This impurity serves as an important reference standard in analytical studies. -
Drug Impurity
Ciprofloxacin impurity 7 is a known impurity associated with the antibiotic ciprofloxacin. This compound is utilized in analytical chemistry to assess the purity of ciprofloxacin formulations. Researchers studying the pharmacological properties and safety profiles of ciprofloxacin can employ this impurity to ensure compliance with regulatory standards. -
Drug Intermediate
2-(4-Pyridyl)-4-methyl-thiazole-5-carboxylic acid is a synthetic intermediate that serves as a crucial building block in pharmaceutical synthesis. This compound enhances the development of complex drug molecules, facilitating various biological activities. Its unique structure makes it valuable for research in medicinal chemistry and the design of novel therapeutic agents. -
Drug Impurity
(S)-Tamsulosin hydrochloride is a chiral impurity associated with the pharmaceutical compound tamsulosin, primarily targeting alpha-1 adrenergic receptors. This reagent may serve a critical role in the analytical characterization and quality control of tamsulosin formulations. Its presence can impact the pharmacological profile and efficacy of the drug, making it an essential component for research and development in pharmaceutical sciences. -
Drug Impurity
Acebutolol impurity 7 is a secondary compound generated during the synthesis of Acebutolol, a selective beta-1 adrenergic receptor blocker. This reagent is primarily utilized in drug development and quality control to ensure the purity and safety of pharmaceutical formulations. Its characterization and analysis are essential for compliance with regulatory standards in chemical research and formulation studies. -
Drug Impurity
Rivaroxaban Impurity 19 is a chemical impurity associated with the anticoagulant Rivaroxaban. It serves as a useful reference standard for quality control and analytical testing in pharmaceutical development. Researchers can utilize this impurity to assess the purity and stability of Rivaroxaban formulations, ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Dabigatran impurity 75 is a chemical impurity associated with the anticoagulant drug Dabigatran. This compound is critical for quality control and characterization in pharmaceutical research, particularly during the assessment of drug purity and compliance with regulatory standards. Its analysis aids in the understanding of the pharmacological profile and safety of Dabigatran formulations, essential for developing and validating drug manufacturing processes. -
Drug Impurity
Rosuvastatin impurity 29 is a identified impurity of the cholesterol-lowering agent, Rosuvastatin. This compound serves as an important indicator for quality control and validation in pharmaceutical formulations. Its characterization is essential for ensuring the safety and efficacy of Rosuvastatin products in clinical research and development. -
Drug Impurity
Mesalazine impurity 5 is a known impurity associated with the anti-inflammatory drug Mesalazine. This compound serves as a critical standard for analytical chemistry, particularly in the quality control and validation of pharmaceutical formulations. Its presence can impact the safety and efficacy of Mesalazine, making it essential for research in drug development and regulatory compliance. -
Drug Impurity
Axitinib Impurity 7 is a chemical reagent associated with the anticancer drug Axitinib. As a drug impurity, it serves as a valuable reference standard for analytical and stability studies. It is essential in the evaluation of the purity, efficacy, and safety of Axitinib formulations in pharmaceutical research. This compound is instrumental in ensuring compliance with regulatory guidelines and conducting thorough quality control assessments. -
Drug Impurity
Meloxicam impurity 5 is an identified impurity of the non-steroidal anti-inflammatory drug (NSAID) Meloxicam. This compound can serve as a reference standard in the analysis of drug formulations and for quality control purposes. Its study can provide insights into the stability, safety, and impurity profiling of pharmaceuticals containing Meloxicam. This impurity is critical for researchers focused on optimizing drug quality and regulatory compliance. -
Drug Impurity
Montelukast impurity 8 is a chemical impurity associated with Montelukast, a leukotriene receptor antagonist used primarily in the management of asthma and allergic rhinitis. This impurity is relevant for method development and validation in pharmaceutical quality control, as well as stability studies and impurity profiling in drug formulation research. Its study aids in understanding the potential effects of impurities on drug safety and efficacy. -
Drug Impurity
Estradiol benzoate impurity 3 is a chemical impurity associated with Estradiol benzoate. This compound serves as a reference standard for quality control and analytical studies involving estradiol formulations. Its identification is essential for ensuring the purity and reliability of estradiol-related products in pharmaceutical research and development. -
Drug Impurity
Prednisolone Impurity 8, also known as Prednisolone 11,21-Diacetate, is a chemical impurity associated with the steroid medication Prednisolone. It serves as a critical reference standard for quality control and analytical testing in pharmaceutical research. This reagent is used to confirm the purity and identity of Prednisolone formulations, assisting in studies related to drug efficacy and safety. -
Drug Impurity
Quetiapine impurity 5 is identified as an impurity associated with the antipsychotic drug Quetiapine. This compound may be utilized in analytical studies to assess the purity of Quetiapine formulations and to investigate potential pharmacological effects related to its impurities. Its characterization is essential for ensuring the quality and safety of pharmaceutical products containing Quetiapine. -
Drug Impurity
Aceclofenac impurity 1 (Diacetic aceclofenac) is identified as an impurity of Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID). This compound is utilized primarily in the quality control and characterization of pharmaceutical formulations containing Aceclofenac. Its presence and concentration can significantly impact the efficacy and safety profile of the final drug product, making it relevant in pharmacokinetic and toxicological studies. -
Drug Impurity
Donepezil impurity 2, also known as Donepezil benzyl bromide, is a notable impurity of Donepezil utilized in pharmaceutical research. Its primary significance lies in drug development and analytical chemistry, where it serves as a reference standard for quality control and impurity profiling. Researchers can employ this compound to ensure the purity and safety of Donepezil formulations, aiding in compliance with regulatory standards. -
Drug Impurity
11-Keto Budesonide is a metabolite of Budesonide, primarily functioning as a drug impurity. It is involved in pharmacokinetic studies and can provide insights into drug metabolism and elimination pathways. Researchers utilize this compound to better understand the stability and degradation of steroid compounds in pharmaceutical formulations. -
Drug Impurity
Methylprednisolone impurity 6 is a recognized impurity associated with Methylprednisolone, a corticosteroid with glucocorticoid properties. This impurity is significant for research related to drug formulation, stability testing, and quality control within pharmaceutical development. It serves as a critical reference for assessing the purity and efficacy of corticosteroid preparations. -
Drug Impurity
Iguratimod impurity 1 is a chemical impurity associated with Iguratimod, which primarily functions as a modulator of the immune response. It is utilized in research to understand the safety, efficacy, and pharmacokinetics of Iguratimod and related compounds. This impurity can support studies on the compound's stability and formulation development in therapeutic applications.
